skip to Main Content

FDA OKs 23andMe Home Breast Cancer DNA Test, with Warning

FDA OKs 23andMe Home Breast Cancer DNA Test, with Warning
The Food and Drug Administration approved the first at-home test that consumers can buy directly to check their breast cancer risk on Tuesday.

The 23andMe test searches for the three DNA mutations that are found most commonly in people of Jewish descent. No doctor’s prescription will be needed for the test. Read more . . .


Back To Top